SEC Form 4 · accession 0001179110-18-001143
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eldon C. Mayer III
Officer — EVP & Chief Commercial Officer
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.49 | Jan 24, 2018 | A | 150,000 | A | — | Jan 24, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018.